Skip to content
SPC Logo

Glypressin 0.12mg/ml Solution for Injection

Last Updated on eMC 13-Sep-2017 View document  | Ferring Pharmaceuticals Ltd Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 13-Sep-2017 and displayed until Current

Reasons for adding or updating:

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 4.8 - Undesirable effects - how to report a side effect

Date of revision of text on the SPC: 05-Sep-2017

Legal Category:POM

Black Triangle (CHM): NO

Free-text change information supplied by the pharmaceutical company:

QRD update and section 4.8 - Yellow card website update 

Updated on 23-Apr-2013 and displayed until 13-Sep-2017

Reasons for adding or updating:

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects

Date of revision of text on the SPC: 15-Mar-2013

Legal Category:POM

Black Triangle (CHM): NO

Free-text change information supplied by the pharmaceutical company:

SPC section 4 updated according to Core Satefy Profile approved during EU PSUR Worksharing procedure.

Updated on 25-Jul-2012 and displayed until 23-Apr-2013

Reasons for adding or updating:

  • Change to MA holder contact details

Date of revision of text on the SPC: 27-Jun-2011

Legal Category:POM

Black Triangle (CHM): NO

Free-text change information supplied by the pharmaceutical company:

New MAH address: Drayton Hall, Church Road, West Drayton, UB7 7PS

Updated on 22-May-2009 and displayed until 25-Jul-2012

Reasons for adding or updating:

  • New SPC for new product

Legal Category:POM

Black Triangle (CHM): NO

Company contact details

Ferring Pharmaceuticals Ltd

Company image
Address

Drayton Hall, Church Road, West Drayton, UB7 7PS, UK

Fax

+44 (0)844 931 0051

Telephone

+44 (0)844 931 0050

Medical Information e-mail

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

terlipressin acetate

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue